BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37325054)

  • 1. PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer.
    Liu L; Li L; Zu W; Jing J; Liu G; Sun T; Xie Q
    J Cancer; 2023; 14(9):1648-1659. PubMed ID: 37325054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL.
    Han H; Fan G; Song S; Jiang Y; Qian C; Zhang W; Su Q; Xue X; Zhuang W; Li B
    Blood; 2021 Mar; 137(12):1603-1614. PubMed ID: 32967010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Huang S; Chen B; Qiu P; Yan Z; Liang Z; Luo K; Huang B; Jiang H
    Transl Cancer Res; 2023 Jun; 12(6):1588-1601. PubMed ID: 37434681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
    Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
    Environ Toxicol; 2023 Jun; 38(6):1455-1465. PubMed ID: 36988233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
    Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
    Genomics; 2023 Jan; ():110566. PubMed ID: 36690262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability.
    Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q
    Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
    Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
    FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
    Zheng H; Cao Z; Lv Y; Cai X
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.
    Liu J; You Y; Sun Z; Zhang L; Li X; Dai Z; Ma J; Chen Y; Jiao G
    Stem Cells Transl Med; 2023 May; 12(5):307-321. PubMed ID: 37010483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
    Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
    FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
    Dai X; Chen K; Xie Y
    Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
    Zhang C; Gu L; Xiao J; Jin F
    BMC Cancer; 2023 Jul; 23(1):684. PubMed ID: 37474926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLOT1, stabilized by WTAP/IGF2BP2 mediated N6-methyladenosine modification, predicts poor prognosis and promotes growth and invasion in gliomas.
    Song T; Hu Z; Zeng C; Luo H; Liu J
    Heliyon; 2023 Jun; 9(6):e16280. PubMed ID: 37260902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.
    You A; Tian W; Yuan H; Gu L; Zhou J; Deng D
    Oncogene; 2022 Aug; 41(32):3925-3938. PubMed ID: 35798874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.
    Wang H; Li C; Wei Q; Zhang E; Yang Y; Sha L; Wang D
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38429603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIWIL1 promotes gastric cancer via a piRNA-independent mechanism.
    Shi S; Yang ZZ; Liu S; Yang F; Lin H
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22390-22401. PubMed ID: 32848063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.